重组人表皮细胞生长因子在慢性溃疡创面中的应用

目的　观察重组人表皮细胞生长因子 (rh EGF)对慢性溃疡创面愈合的影响。方法　 1999年 10月～ 2 0 0 1年 1月在局部清创后随机对 2 6例患者的慢性溃疡创面 (3cm× 3cm～ 5 cm× 8cm )作为治疗组 ,用rh EGF喷雾剂以 40 0 U / 10 cm2 进行局部喷涂 ,无菌敷料覆盖 ;同期随机对另 2 6例慢性溃疡创面 (2 .5 cm×3.0 cm～ 4.0 cm× 6 .5 cm )用 0 .9%生理盐水进行局部湿敷作为对照组 ,观察创面愈合时间、创面局部及全身反应情况。结果　治疗组中创面不适感消失早 ,脓性分泌物少 ,肉芽组织生长快 ,无过度增生现象。溃疡创面愈合时间治疗组较对照组缩短 7～ 10天 ,经统计学处理 ,有显著性差异 (P<0 .0 1)。结论　 rh EGF有明显促进慢性溃疡创面愈合的作用 ,且愈合时间短、质量好

APPLICATION OF RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR ON CHRONIC U LCER WOUND

OBJECTIVE: To observe the effect of recombinant human epidermal growth factor (rhEGF) on healing of chronic ulcer wound. METHODS: From January 1999 to January 2001, twenty-six patients with chronic wounds were adopted in this study. Among them, there were 17 males and 9 females, aged from 12 to 61 years. The area of the chronic wound varied from 3 cm x 3 cm to 5 cm x 8 cm and the disease course was 7 to 16 days. These patients were treated with rhEGF in the way of sprinkling locally (400 U/10 cm2). Another 26 patients with chronic wounds were adopted as the control group and were treated with 0.9% saline in the same way. The healing time of wounds and the local and systemic reactions of patients were observed. RESULTS: The healing time of chronic wounds was shorter obviously to about 7 days with rhEGF than that of the control group and there was significant difference between the two groups(P < 0.01). CONCLUSION: rhEGF can obviously promote the healing of chronic ulcer wound.